VSee Health enters USD 336,000 convertible note financing with Labrys

VSee Health entered a securities purchase agreement with Labrys on June 30, 2026 for an unsecured convertible promissory note.

• Aggregate principal amount: USD 336,000, including a USD 36,000 original issue discount; one-time 12% interest charge earned in full at issuance.
• The note matures on June 30, 2027; the company can prepay before day 181, subject to a percentage-based cash repayment amount.
• Labrys can require up to 50% of cash proceeds received before repayment to be applied to repay outstanding principal and interest.
• Conversion is allowed after certain triggers; the conversion price is set at 75% of the lowest closing bid in the prior 10 trading days, capped at 4.99% ownership.